Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Enlisting the mRNA Vaccine Platform to Combat Parasitic Infections
Leroy Versteeg, Mashal M. Almutairi, Peter J. Hotez, et al.
Vaccines (2019) Vol. 7, Iss. 4, pp. 122-122
Open Access | Times Cited: 83

Showing 1-25 of 83 citing articles:

mRNA-based therapeutics: powerful and versatile tools to combat diseases
Shugang Qin, Xiaoshan Tang, Yu‐Ting Chen, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 411
Paving the Road for RNA Therapeutics
Niels Dammes, Dan Peer
Trends in Pharmacological Sciences (2020) Vol. 41, Iss. 10, pp. 755-775
Open Access | Times Cited: 188
Formulation and Delivery Technologies for mRNA Vaccines
Chunxi Zeng, Chengxiang Zhang, Patrick Walker, et al.
Current topics in microbiology and immunology (2020), pp. 71-110
Open Access | Times Cited: 179
mRNA vaccines for COVID-19 and diverse diseases
Abid Hussain, Haiyin Yang, Jun Zhang, et al.
Journal of Controlled Release (2022) Vol. 345, pp. 314-333
Open Access | Times Cited: 83
Identification of vaccine targets in pathogens and design of a vaccine using computational approaches
Kamal Rawal, Robin Sinha, Bilal Ahmed Abbasi, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 98
The 2020 race towards SARS-CoV-2 specific vaccines
Tomasz M. Karpiński, Marcin Ożarowski, Agnieszka Seremak‐Mrozikiewicz, et al.
Theranostics (2020) Vol. 11, Iss. 4, pp. 1690-1702
Open Access | Times Cited: 91
Microfluidic fabrication of lipid nanoparticles for the delivery of nucleic acids
Gyan Prakash, Ahmed Shokr, Niels Willemen, et al.
Advanced Drug Delivery Reviews (2022) Vol. 184, pp. 114197-114197
Open Access | Times Cited: 55
Leishmania Vaccines: the Current Situation with Its Promising Aspect for the Future
Raşit Dinç
Korean Journal of Parasitology (2022) Vol. 60, Iss. 6, pp. 379-391
Open Access | Times Cited: 41
Thermostable vaccines: an innovative concept in vaccine development
Ravinder Kumar, Vartika Srivastava, Piyush Baindara, et al.
Expert Review of Vaccines (2022) Vol. 21, Iss. 6, pp. 811-824
Closed Access | Times Cited: 38
Self-Amplifying RNA Approach for Protein Replacement Therapy
Dimitri Papukashvili, Nino Rcheulishvili, Cong Liu, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 12884-12884
Open Access | Times Cited: 38
Immunotherapies against human bacterial and fungal infectious diseases: A review
Hafsa Qadri, Abdul Haseeb Shah, Mustfa Alkhanani, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 24
The mRNA Vaccine Technology Era and the Future Control of Parasitic Infections
Hong You, Malcolm K. Jones, Catherine A. Gordon, et al.
Clinical Microbiology Reviews (2023) Vol. 36, Iss. 1
Open Access | Times Cited: 22
Harnessing RNA Technology to Advance Therapeutic Vaccine Antigens against Chagas Disease
Chiara Mancino, Jeroen Pollet, Assaf Zinger, et al.
ACS Applied Materials & Interfaces (2024) Vol. 16, Iss. 13, pp. 15832-15846
Open Access | Times Cited: 8
Leishmania vaccine development: A comprehensive review
Isha Saini, Jyoti Joshi, Sukhbir Kaur
Cellular Immunology (2024) Vol. 399-400, pp. 104826-104826
Closed Access | Times Cited: 8
mRNA Technology in Modern Medicine: Review and Future Prospects
Heslley Machado Silva
Deleted Journal (2025) Vol. 2, pp. 1-1
Closed Access | Times Cited: 1
From Bench to the Clinic: The Path to Translation of Nanotechnology-Enabled mRNA SARS-CoV-2 Vaccines
Diana O. Lopez-Cantu, Xichi Wang, Hector Carrasco-Magallanes, et al.
Nano-Micro Letters (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 37
Nanoparticles: Synthesis and Their Role as Potential Drug Candidates for the Treatment of Parasitic Diseases
Hammad Ur Rehman Bajwa, Muhammad Kasib Khan, Zaheer Abbas, et al.
Life (2022) Vol. 12, Iss. 5, pp. 750-750
Open Access | Times Cited: 34
Convalescent plasma (hyperimmune immunoglobulin) for COVID-19 management: An update
Vivek P. Chavda, Rajashri Bezbaruah, Sheetal Dolia, et al.
Process Biochemistry (2023) Vol. 127, pp. 66-81
Open Access | Times Cited: 17
Progress and prospects of mRNA-based drugs in pre-clinical and clinical applications
Yingying Shi, Miaoyuan Shi, Yì Wáng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 6
Recent advances in immunotherapies against infectious diseases
Dharanidharan Ramamurthy, Trishana Nundalall, Sanele Cingo, et al.
Immunotherapy Advances (2020) Vol. 1, Iss. 1
Open Access | Times Cited: 49
A domain-based vaccine construct against SARS-CoV-2, the causative agent of COVID-19 pandemic: development of self-amplifying mRNA and peptide vaccines
Mohammad M. Pourseif, Sepideh Parvizpour, Behzad Jafari, et al.
Bioimpacts (2020) Vol. 11, Iss. 1, pp. 65-84
Open Access | Times Cited: 49
Recent Progress in the Development of Liver Fluke and Blood Fluke Vaccines
Donald P. McManus
Vaccines (2020) Vol. 8, Iss. 3, pp. 553-553
Open Access | Times Cited: 46
Establishing Preferred Product Characterization for the Evaluation of RNA Vaccine Antigens
Cristina Poveda, Amadeo B. Biter, María Elena Bottazzi, et al.
Vaccines (2019) Vol. 7, Iss. 4, pp. 131-131
Open Access | Times Cited: 45
mRNA, a Revolution in Biomedicine
Bruno Baptista, Rita Carapito, Nabila Laroui, et al.
Pharmaceutics (2021) Vol. 13, Iss. 12, pp. 2090-2090
Open Access | Times Cited: 37
Ecological and socioeconomic factors associated with the human burden of environmentally mediated pathogens: a global analysis
Susanne H. Sokolow, Nicole Nova, Isabel J. Jones, et al.
The Lancet Planetary Health (2022) Vol. 6, Iss. 11, pp. e870-e879
Open Access | Times Cited: 25
Page 1 - Next Page

Scroll to top